chrisvoncsefalvay/vaers-outcomes huggingface dataset:
puruitic papular rash all over trunk, onset 48h after vaccine.  She did not seek treatment, but did call office on 10/16 to report improvement/near resolution of rash.
Pt had a ground level fall at group home and was found to be hypoxic, requiring 2L NC and tested positive for COVID 19.
Patient had requested bivalent booster dose but incorrect vial had been pulled from freezer by technician and not caught by pharmacist.  3 doses given and not caught until scanned into system.
fever of 104.6; chills; rash from her ankle to her knees that she describes as blotches. they were not itchy.; achy; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 72-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 28Feb2021 as dose 1, single dose for COVID-19 immunization. The patient states she is scheduled to receive her second dose on 21Mar2021. The patient states she has allergies to metal, shellfish her lip blew up, and iodine. The patient concomitant medications were not reported. The patient states the first day she was fine and the second day she was just achy and then on the fourth day which was Thursday she had a fever of 104.6, chills, and a rash from her ankle to her knees that she describes as blotches. The patient states they were not itchy. The patient would like to know if she should receive the second dose of the vaccine. The patient would like to know if there is any metal or aluminum in the vaccine. The patient would like to have a list of ingredients in the vaccine. The patient states she spoke to her health care provider, and they told her she should not receive the second dose, but it was up to her. The patient would like to know if anyone has reported a fever of 104.6 after the first dose of the vaccine. The patient declined to give more information stating she was at work and needed to get off the phone. The patient was given website name to report adverse reaction. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Initial report was received from a healthcare professional on 21 September 2010. A male patient with an unreported past medical history, had received FLUZONE High Dose, lot number U3617AA (date, route and site of administration not reported) and an unspecified amount of time later, experienced nausea, vomiting and "green discharge from the eyes". The patient was sent to the emergency room (ER) "four hours after vaccine" and was admitted for 24 hour observation. The reporter stated the patient had "some" laboratory (lab) tests (results not reported). She was not aware if any cultures were taken. The patient was discharged from the hospital (date not reported). No further information was available at the time of this report. The patient's outcome was not reported. The reporter for this case is the same as for case 2010-05250. Documents held by sender: none
13 days after vaccine booster started having sharp pain running up left side of neck and behind left ear.  I felt like my neck was filling up with fluid and could even hear gushing sound of liquid in neck.  Pain continued and second night family witnessed left eye open while sleeping.  Third day awoke and left side of face felt numb and still had pain in neck and behind left ear.  Fourth day had all previous symptoms plus complete paralysis of left side of face.  Left eye could not close, left eye continual tearing, left side of mouth not movable, drooling, eye brow not movable and loss of taste.  Whole left side of face drooping.
Reacts with any shot he receives, he fainted, very quick respons no add'l med. intervention needed.
Complex febrile seizure 16 1/2 hours after receiving PREVNAR 13 and PENTACEL vaccines requiring 9-1-1 to be called sl overnight hospitalization.
Vomiting. Diarrhea. Intussusception.   11/30/09 Medical records received for DOS 9/1-9/4.  Final DX:  Intussusception Status Post, Status Post LAP Appendectomy, Dehydration Resolved.     Vomiting. Cough and runny nose w/GI sx. Intussusception non-reducible. Subsequently surgically reduced. Appendectomy performed and penile foreskin adhesions removed as well.  Back to baseline.
Child received his 4th DTaP on 10/24/03 and returned to clinic on 10/27/03 for TB reading. Mother states that his L deltoid area where DTaP was given became quite red and swollen. Child is still guarding his arm. Area has a pinkish rim about 4" in diameter that appears to be resolving swelling and erythema. Counseled mother regarding local treatment and age appropriate pain reliever.
Pain at site, redness, swelling and hot to touch. Vaccine and reaction to the right arm.
Patient presented to pharmacy on 7/10/2018 with redness approximately 3 to 5 inches around injection site. Area was warm to touch. Patient contacted on 7/12/2008 to follow-up and patient reported improvement (little redness left in area).
My skin became extremely dry.  On my legs, it looked like the texture and pattern of snake skin.  On my hands, the skin between each finger and around where the fingers attach to my hands peeled and were raw for 9 weeks.  Some of the skin on my hands got so thin, it broke open and thinned.  It hurt to even run water on my hands.   On June 17th, I had a skin biopsy at my annual dermatologist appointment.  They covered the area with a band-aid.  I have not reacted to band-aids before, but within 36 hours, I had sores where the adhesive had been on my skin.  They were red, raised, and painful.  I thought maybe it was something in the band-aid that the dermatologist office used, so I switched to my own band-aids from home and placed the band-aid up and down, instead of across.  I got sores from that, too.  I tried Benadryl cream, cortisone, cream, peroxide, bacitracin, and a couple of other products.  Nothing helped it.   I was at another doctors appointment, and that doctor saw the raised red spots on my arm from the band-aids and asked about it.  He recommended Clobetasol twice a day for 7 days.  That has finally helped.     The sores are not completely gone, but they are healing.  Today is July 25, 2021.  It has been one month and 8 days since the problem started.  I am concerned moving forward with how my skin will react to band-aids/adhesive.
I have a few large red blotchy patches on the left side of my body. They are on my left arm, the left side of my torso, and the upper left portion of my chest.   They are not painful and do not itch.
Covid Moderna administered 12/23/20, 2 PM 15 min later, tingling lower left face. Numbness inc 1-2 hrs, tingling down to left arm (IM site). Resolved in 2 days
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. No concurrent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II (therapy type: rHA, lot# K014833, expiration date 14-SEP-2016; strength, dose and route unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient's mouth started to swell along with getting lumps on the roof of her mouth and back of her throat. Patient was given BENADRYL which brought down swelling.
Day 1 totally exhausted and slept for 24 hrs.  Day 2 totally exhausted. Day 3 felt better but tired. Day 4 woke up dizzy and exhausted. Day 5 dizzy and exhausted. Day 6 dizzy and exhausted. Day 7 dizzy and exhausted. Day 8 still dizzy and tired, but beginning to feel better. Slightly dizzy for days 9, 10, and 11. This affected my work where I couldn't work.  I will not get the second shot.
Pt broke out in full body rash consisting of small, red, itchy dots 10 days after vaccine was administered.  Pt saw a dermatologist who told him he had chicken pox and prescribed an "antihistamine and sav (steroid cream)" according to the patients spouse.  No oral or respiratory symptoms have been reported.
12/13/2005 Mom here for WIC check pick-up and stated baby cried high pitched X 3 days for 3 hrs. at a time after shots given on 12/8/05.  Left thigh was reddened (as per mom).  Observed a quartered sized area of hardness on L thigh.  This is where Pediarix was given. No fever, seizures, according to mom.  Mom states child appears to be "getting better as of today".  Has had one bout of diarrhea this A.M. Spoke with State Dept. of Health, who stated the VAERS form should be filled out.  Previously, this child received DTaP as a single shot.  Also this child received Comvax (Hib & Hep B) previously.
Flublok provided to patient in right arm first.  Engerix B given in the left arm (1st of 3 doses).  Immediately after injection, patient's left deltoid began swelling up to a golf-ball size at the injection site.  Patient also began to feel dizzy.  Pharm D brought ice to help reduce swelling after having patient lie down on the floor to help dizziness.  Patient's PCP was called to advise.  Per PCP (who spoke to pt directly while in presence of PharmD), continue icing and pt can still receive subsequent doses of vaccine.  After lying down for 10 minutes, pt began feeling better.  He was able to walk on his own and return to work same day.
Information was received on 13-OCT-2017 regarding a case in litigation from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were unknown. The patient was inoculated with ZOSTAVAX (lot number and expiration not reported), subcutaneous on or about 29-SEP-2012 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 23-JUN-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. The patient has been prescribed gabapentin and famciclovir for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
This spontaneous case reported by a nurse, describes the occurrence of off label use (second dose administered on day 21) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006C21A) for COVID-19 immunization. No medical history reported. On May 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 1, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 1, 2021, patient experienced off label use (second dose administered on day 21). On Jun 1, 2021, off label use (second dose administered on day 21) resolved. The reporter did not provide any causality assessments, concomitant medication  or treatment information. Action taken with mRNA-1273 in response to the events: not applicable.
1000 on 1/5 states she developed a headache and neck and back pain. Later that evening was fuzzy thinking. When walking got lightheaded and dizzy. Friday middle of the night had pain in stomach and nauseated. Saturday and Sunday, was nauseated and fatigued and dizzy. States she stayed in bed all weekend. Today states she feels nauseated and stomach hurt. On Monday right arm started hurting from the lateral antecubital down to wrist. States she didn't take anything for it until last night 2 regular TYLENOL and yesterday took 2 ADVIL. Today took two Ibuprofen in the afternoon. States the medication helps some.
Head ache, chills, fever, bone ache, chest pains, exhaustion,nausea, swollen glands, rash, ear ache, dizziness, difficulty breathing, joint pain., ear aches, jaw and teeth aches.
90 mins after Hepatitis B shot pt had chest pain, SOB and lump in throat.
Feeling dehydrated, pain and discomfort in left arm and shoulder, feeling very hot but no fever
"3 days after vaccination pt developed a fever and her tongue and throat began to swell." TX: "Prednisone, cimetadine". - Pt tx in ER. - Pt reported this information.
area is a raised lump like a mosquito bite; area is hard; area is swollen; big red circle around the injection site/ red dot where the injection went into her arm; arm sore at injection site; red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (area is a raised lump like a mosquito bite), VACCINATION SITE INDURATION (area is hard), VACCINATION SITE PAIN (arm sore at injection site), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE SWELLING (area is swollen) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 15-Mar-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021 at 9:00 PM, the patient experienced VACCINATION SITE PAIN (arm sore at injection site) and VACCINATION SITE ERYTHEMA (red at injection site). On 23-Mar-2021, the patient experienced VACCINATION SITE MASS (area is a raised lump like a mosquito bite), VACCINATION SITE INDURATION (area is hard), VACCINATION SITE SWELLING (area is swollen) and VACCINATION SITE ERYTHEMA (big red circle around the injection site/ red dot where the injection went into her arm). On 17-Mar-2021, VACCINATION SITE PAIN (arm sore at injection site) and VACCINATION SITE ERYTHEMA (red at injection site) had resolved. At the time of the report, VACCINATION SITE MASS (area is a raised lump like a mosquito bite), VACCINATION SITE INDURATION (area is hard), VACCINATION SITE SWELLING (area is swollen) and VACCINATION SITE ERYTHEMA (big red circle around the injection site/ red dot where the injection went into her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
fever; chills; lower back pain; swollen lymph nodes under arms; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 01May2021 at 09:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 03Apr2021 at 10:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced fever, chills, lower back pain and swollen lymph nodes under arms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, lower back pain and swollen lymph nodes under arms were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 01-APR-2016, the patient was inadvertently vaccinated with an expired dose of MMR II lot # K003822 and expiration date: 14-MAR-2016 (dose and route of administration were not reported). No adverse effect was reported. Additional information has been requested.
pain in upper arm on first two-3 days, then moving to left hip area for 2-3 days, then moving also to left knee and leg.
3 days after Yellow Fever injection, noticed redness to injection site in right upper arm, felt nauseated.
No additional AEs/no PQCs.; Pharmacy student reported that a patient was administered MMR-II intramuscularly on 12/30/2022.; This spontaneous report was received from a pharmacy student and referred to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history and drug reactions/allergies were not provided.  On 30-DEC-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (strength, dose, lot #, expiry date and anatomical location were not provided) intramuscularly for prophylaxis (incorrect route of product administration). No additional adverse events (AEs) reported (no adverse event).
Patient was asymptomatic and tested positive for COVID-19 on 4/23/2021 prior to having a procedure.
Second dose I am 8 days late; This is a spontaneous report from a contactable consumer (patient). A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration (Age at time of vaccination: 24) in Apr2021, as dose 2, single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown) via an unspecified route of administration (Age at time of vaccination: 24) in Mar2021, as dose 1, single dose for COVID-19 immunisation. After the first dose patient's periods was 3 days late and very light. Patient reported past drug history as no. Patient was not received any other vaccines within 4 weeks prior to the COVID vaccine and no other medications received within 2 weeks of vaccination. Prior to vaccination patient was not diagnosed with COVID-19 reported as no and after vaccination patient was tested for COVID-19 reported as yes. After second dose in May, the patient experienced periods was 8 days late. The patient underwent lab tests and procedures which included pregnancy test: negative, on 2021 patient had taken 4 pregnancy test and sars-cov-2 test: negative on Apr2021, post vaccination. The patient had a physician office visit. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt. given FLUVIRIN vaccination in left deltoid. Pt. reported severe pain with arm or shoulder movement. Pt. called on 10-25-12 and still reports that shoulder is sore. She will follow up with MD in one week.
Information has been received from a registered pharmacist concerning a 42 year old male who on 31-OCT-2008 (also reported as "31-DEC-2008") was vaccinated with PNEUMOVAX (Lot # 662661/0978X) intramuscularly (total daily dose not reported). Subsequently the patient developed 13x17cm red area and running 102 temp and the patient went to ER and started on BIAXIN. At the time of the report the patient recovered from 13x17cm red area and running 102 temp. This is one of several reports received from the same source. No further information is available.
patient had 3rd (booster) dose of Pfizer COVID vaccine on 12/29/2021 and then around 1/5/2022 had onset of flank rash bilaterally and angioedema on lips; around this time also found to be diagnosed with covid19.  hospitalized for the angioedema but improved with steroids and antihistamines.  no other new obvious precipitant could be identified to cause angioedema, so this report was filed, given my assumption that vaccine could have possibly played a role.
Immediately after the vaccines were administered, the client reported that he felt dizzy to the medical assistant who administered the vaccines. The medical assistant alerted me and I entered the exam room. The client reported that he felt dizzy, nauseous, and weak. He was warm and clammy and had difficulty holding his head up. He was instructed to stay sitting and given water to drink. I administered smelling salts, which did not have a visible impact on the client. I obtained a blood pressure of 96/60. A cold compress was applied to the back of his neck. Another nurse entered and did a sternal rub, which aroused the client. She obtained a radial pulse of 88. The client was given apple juice to drink and we aimed a fan at him. A second blood pressure was taken and the result was 102/68. The client began to feel better but still reported weakness. He was offered a snack but declined. After approximately 15 minutes, he reported significant improvement and his mother insisted that they move to the waiting area. The mother and I assisted him to a chair where his condition continued to improve. About 5 minutes later the client ambulated out of the clinic independently. The client did not lose consciousness at any time.
Initial unsolicited pregnancy report received from a nurse on 04-Dec-2015. This case involves a 39-year-old female patient, who was vaccinated with intramuscular first dose of ADACEL (batch number: U5263AA, expiry date: 21-Jan-2018 and site of administration was not reported) on 04-Dec-2015. The last menstrual period was not reported. Estimated date of delivery was reported as 08-Jan-2016. Pregnancy history reported as none, other medical history and concomitant medications were not reported. Information regarding fertility treatment were not reported. At the time of vaccination the patient was 38 weeks pregnant (Third trimester). At the time of this report, it was unknown whether the patient experienced any adverse events. Documents held by sender: none. Follow up information received from physician on 09 February 2016. Last menstrual period (LMP) was reported as 29 March 2015 and estimated delivery date was 3 January 2016. Week of gestation was 33 (reported as 37 week). Patient's medical history included HPV. The patient had immunization with Rubella and Toxoplasmosis was negative. The patient was former smoker. Concomitant medication included prenatal vitamin. It was reported that the patient had hypertension after delivery. The patient received corrective treatment with labetalol 100 mg oral twice a day for hypertension. Prenatal testing included alpha fetal protein (and other serum makers) on 28 July 2015, uterine ultrasound on 5 August 2015, genetic screening on 8 June 2015 revealed cystic fibrosis fragile X SMA (spinal muscular atrophy). Patient gave birth to live normal baby (male) on 13 December 2015 via normal vaginal delivery. Outcome of the event hypertension after delivery was not reported. Follow up information received from physician on 26 February 2016. It was reported that the patient had no hypertension prior to vaccination. No further information was provided.
Approx.10 hours after the two injections, I started to have a full body ache.  After bed I woke at about 1:30 am, with high fever,stiff muscles and full body aches,more severe than at bedtime.  I also had an intense headache.  Affect lasted about 18 hours.  Note: unsure of the exact Tdap I received it was not listed on the paperwork.